Literature DB >> 12623993

Intracellular mechanisms involved in leptin regulation of sympathetic outflow.

Kamal Rahmouni1, William G Haynes, Donald A Morgan, Allyn L Mark.   

Abstract

Leptin acts in the hypothalamus to decrease appetite and increase sympathetic nerve activity. The leptin receptor is known to signal through the janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway to modulate transcription of target genes. Alteration of the activity of phosphoinositol-3 kinase (PI3K) by leptin has also been reported, and inhibition of PI3K is known to block the leptin-induced suppression of feeding. We tested the hypothesis that leptin-induced renal sympathetic nerve activation is mediated by PI3K. We evaluated renal sympathetic nerve activity (RSNA) and feeding responses of C57BL/6J mice to intracerebroventricular (ICV) administration of leptin in the presence or absence of selective inhibitors of PI3K (LY294002 or wortmannin). As expected, ICV administration of leptin decreased food intake at 4 hours and 24 hours and increased RSNA. Pretreatment with the PI3K inhibitor LY294002 markedly attenuated both the decrease in food intake and the increase in RSNA induced by leptin. Wortmannin also inhibited the RSNA response to leptin. In contrast, PI3K inhibitors did not affect the RSNA response to MTII (melanocortin-3/4 receptor agonist). Our data demonstrate that PI3K appears to play an important role in the transduction of leptin-induced changes in renal sympathetic outflow.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12623993     DOI: 10.1161/01.HYP.0000048342.54392.40

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  49 in total

Review 1.  Brain effects of leptin: what intracellular mechanism?

Authors:  Kamal Rahmouni
Journal:  Curr Diab Rep       Date:  2003-12       Impact factor: 4.810

Review 2.  Sympathetic nervous system in obesity-related hypertension: mechanisms and clinical implications.

Authors:  Graziela Z Kalil; William G Haynes
Journal:  Hypertens Res       Date:  2011-11-03       Impact factor: 3.872

Review 3.  Selective leptin resistance revisited.

Authors:  Allyn L Mark
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-07-24       Impact factor: 3.619

4.  Regulation of Blood Pressure, Appetite, and Glucose by Leptin After Inactivation of Insulin Receptor Substrate 2 Signaling in the Entire Brain or in Proopiomelanocortin Neurons.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Nathan J Freeman; Ammar J Alsheik; Ahmad Adi; John E Hall
Journal:  Hypertension       Date:  2015-11-30       Impact factor: 10.190

Review 5.  From observation to experimentation: leptin action in the mediobasal hypothalamus.

Authors:  Kevin W Williams; Michael M Scott; Joel K Elmquist
Journal:  Am J Clin Nutr       Date:  2009-01-28       Impact factor: 7.045

Review 6.  Control of respiratory and cardiovascular functions by leptin.

Authors:  M Bassi; W I Furuya; D B Zoccal; J V Menani; E Colombari; J E Hall; A A da Silva; J M do Carmo; D S A Colombari
Journal:  Life Sci       Date:  2015-01-30       Impact factor: 5.037

Review 7.  Neural Control of Non-vasomotor Organs in Hypertension.

Authors:  Chansol Hurr; Colin N Young
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

8.  Mechanisms mediating renal sympathetic activation to leptin in obesity.

Authors:  Donald A Morgan; Daniel R Thedens; Robert Weiss; Kamal Rahmouni
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-09-24       Impact factor: 3.619

9.  Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice.

Authors:  Jennifer W Hill; Kevin W Williams; Chianping Ye; Ji Luo; Nina Balthasar; Roberto Coppari; Michael A Cowley; Lewis C Cantley; Bradford B Lowell; Joel K Elmquist
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

Review 10.  The role of the sympathetic nervous system in obesity-related hypertension.

Authors:  Alexandre A da Silva; Jussara do Carmo; John Dubinion; John E Hall
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.